• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Amgen

Amgen

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Amgen Issues Voluntary Recall of Aranesp® (darbepoetin alfa) (500 mcg) Prefilled Syringes in Several Countries Outside of the United States Due to the Presence of Visible Particulates

    Amgen Issues Voluntary Recall of Aranesp® (darbepoetin alfa) (500 mcg) Prefilled Syringes in Several Countries Outside of the United States Due to the Presence of Visible Particulates

  2. UPDATE: Nasdaq breaks out, reaches -4-

    UPDATE: Nasdaq breaks out, reaches -4-

  3. UPDATE: Nasdaq breaks out, reaches -4-

    UPDATE: Nasdaq breaks out, reaches -4-

  4. Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37

    Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37

  5. Amgen reports successful late-stage trial of cancer treatment

    Amgen reports successful late-stage trial of cancer treatment

  6. UPDATE: CORRECT: Amgen shares fall after-hours on disappointing trial data

    UPDATE: CORRECT: Amgen shares fall after-hours on disappointing trial data

  7. UPDATE: CORRECT: Amgen shares fall after-hours on disappointing trial data

    UPDATE: CORRECT: Amgen shares fall after-hours on disappointing trial data

  8. UPDATE: Wal-Mart, Cisco are stocks to watch Thursday

    UPDATE: Wal-Mart, Cisco are stocks to watch Thursday

  9. Wal-Mart, Cisco are stocks to watch Thursday

    Wal-Mart, Cisco are stocks to watch Thursday

  10. Avion Pharmaceuticals, LLC, signs Captisol® License Agreement with Ligand Pharmaceuticals to develop four new products

    Avion Pharmaceuticals, LLC, signs Captisol® License Agreement with Ligand Pharmaceuticals to develop four new products

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.